Shawn Davis, CEO of Liberate Bio, shares some insights into the world of drug discovery, development, and delivery, as well as process optimization
Joe Petroziello
Advertisement
Joe Petroziello is Executive Vice President, Head of Global Medical Affairs & Corporate Development at MJH Life Sciences.
Articles by Joe Petroziello
Gabi Hanna, MD, CEO and co-founder of Lamassu Pharma talks about a novel oncology platform and the link between science and patient care.
Novel approaches against chronic inflammation could potentially prevent certain inflammatory diseases and neurological conditions.
At BIO 2024 in San Diego, John Dunlop, PhD, chief scientific officer at Aliada Therapeutics, sat down for an interview with Pharmaceutical Technology to discuss the firm’s MODEL platform and its potential impact on therapeutic delivery for brain-related conditions.
Advertisement
Latest Updated Articles
Lamassu Pharma Bridges Scientific Knowledge and Patient CarePublished: June 17th 2024 | Updated:
Pushing Boundaries to Revolutionize Chronic Inflammation TherapyPublished: June 14th 2024 | Updated:
Therapeutic Delivery for Brain-Related ConditionsPublished: June 12th 2024 | Updated:
Improving the Efficacy of Genetic MedicinesPublished: July 5th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Frankfurt 2025: Regulatory Challenges for Global Manufacturing of Vaccines
2
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
3
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
4
CPHI Frankfurt 2025: The Current API Market
5
